Fagron Sterile Services will participate in the FDA's Compounding Quality Center of Excellence Annual Conference held online September 11-13. FSS' Senior Director of Quality at the Boston location, Deb McHugh, will once again be serving as a panelist for the conference.Visit Tradeshow Website
September 11, 2023
September 13, 2003
Fagron Sterile Services US (FSS), a top-tier DEA and FDA-Registered 503B Outsourcing Provider, produces a reliable supply of high-quality sterile medications with cGMP compliant operations for patient-focused healthcare facilities across North America. FSS' team employs expertise in legal and regulatory compliance, pharmaceutical manufacturing and repackaging, leveraging industry leading automation, advanced environmental monitoring and sophisticated in-house quality testing labs. Batches are validated to support Beyond Use Dating (BUD) and only released after successful sterility, particulate matter and potency testing are complete. FSS offers a broad product portfolio across Operating Room Anesthesia (OR Syringes & IV Bags), Ophthalmics, Pain Management, and other Specialty Presentations, while holding Integrated Delivery Network (IDN)agreements within all major GPOs.